A. K. Kakkar

5.2k total citations · 2 hit papers
46 papers, 2.7k citations indexed

About

A. K. Kakkar is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, A. K. Kakkar has authored 46 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Internal Medicine, 24 papers in Cardiology and Cardiovascular Medicine and 10 papers in Hematology. Recurrent topics in A. K. Kakkar's work include Venous Thromboembolism Diagnosis and Management (27 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). A. K. Kakkar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (27 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). A. K. Kakkar collaborates with scholars based in United Kingdom, Canada and United States. A. K. Kakkar's co-authors include Gary E. Raskob, Elaine M. Hylek, Stavros Konstantinides, Pantep Angchaisuksiri, A Blanco, Micah McCumber, Aaron M. Wendelboe, Harry R. Büller, Alexander Gallus and Yukio Ozaki and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gut.

In The Last Decade

A. K. Kakkar

42 papers receiving 2.6k citations

Hit Papers

Thrombosis 2014 2026 2018 2022 2014 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Thrombosis
    2014 744 citations Gary E. Raskob, Pantep Angchaisuksiri et al. profile →
  2. Thrombosis: a major contributor to the global disease burden
    2014 344 citations Gary E. Raskob, Pantep Angchaisuksiri et al. Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. K. Kakkar United Kingdom 21 2.0k 1.4k 600 573 322 46 2.7k
Ramón Lecumberri Spain 27 1.6k 0.8× 1.2k 0.8× 374 0.6× 624 1.1× 339 1.1× 110 2.3k
Alejandro Lazo‐Langner Canada 29 1.6k 0.8× 1.0k 0.7× 588 1.0× 696 1.2× 372 1.2× 169 3.2k
J Weitz Canada 14 1.5k 0.7× 845 0.6× 401 0.7× 456 0.8× 229 0.7× 22 2.1k
Theodore E. Spiro United States 29 2.5k 1.2× 2.3k 1.7× 879 1.5× 319 0.6× 218 0.7× 66 3.4k
Lori‐Ann Linkins Canada 27 2.2k 1.1× 1.4k 1.0× 1.4k 2.3× 703 1.2× 298 0.9× 64 3.0k
A Blanco Argentina 15 1.1k 0.6× 736 0.5× 352 0.6× 709 1.2× 134 0.4× 52 1.9k
Edelgard Lindhoff‐Last Germany 34 1.9k 1.0× 1.8k 1.3× 1.3k 2.2× 1.0k 1.8× 83 0.3× 148 3.7k
Pantep Angchaisuksiri Thailand 30 1.9k 0.9× 1.3k 0.9× 561 0.9× 1.6k 2.8× 292 0.9× 111 3.9k
O.E. Dahl Norway 21 2.3k 1.2× 2.2k 1.6× 806 1.3× 316 0.6× 114 0.4× 30 2.9k
Rohan Hettiarachchi Netherlands 12 2.0k 1.0× 1.9k 1.4× 630 1.1× 306 0.5× 144 0.4× 12 2.5k

Countries citing papers authored by A. K. Kakkar

Since Specialization
Citations

This map shows the geographic impact of A. K. Kakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. K. Kakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. K. Kakkar more than expected).

Fields of papers citing papers by A. K. Kakkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. K. Kakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. K. Kakkar. The network helps show where A. K. Kakkar may publish in the future.

Co-authorship network of co-authors of A. K. Kakkar

This figure shows the co-authorship network connecting the top 25 collaborators of A. K. Kakkar. A scholar is included among the top collaborators of A. K. Kakkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. K. Kakkar. A. K. Kakkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kakkar, A. K., et al.. (2025). Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms. Journal of Alzheimer s Disease. 108(1). 19–41.
2.
Haas, Sylvia, Walter Ageno, Harald Darius, et al.. (2019). Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry. Hämostaseologie.
3.
Mulder, Frits I., Nick van Es, Noémie Kraaijpoel, et al.. (2018). Efficacy and safety of edoxaban in clinically relevant subgroups: results from the Hokusai VTE Cancer randomized trial. Thrombosis Research. 164. S194–S194. 5 indexed citations
4.
Wendelboe, Aaron M., Micah McCumber, Elaine M. Hylek, et al.. (2015). Global public awareness of venous thromboembolism. Journal of Thrombosis and Haemostasis. 13(8). 1365–1371. 97 indexed citations
5.
6.
Kakkar, A. K., Jean‐Pierre Bassand, Samuel Z. Goldhaber, et al.. (2013). One-year outcomes in atrial fibrillation patients with versus without a previous stroke or transient ischaemic attack: findings from the international prospective GARFIELD registry. European Heart Journal. 34(suppl 1). P386–P386. 1 indexed citations
7.
Lassen, Michael R., Winfield S. Fisher, Patrick Mouret, et al.. (2012). Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE. Journal of Thrombosis and Haemostasis. 10(5). 822–832. 20 indexed citations
8.
Girolamo, A. Di, A. K. Kakkar, M. Litmaath, et al.. (2012). New solutions for large scale functional tests in the WLCG infrastructure with SAM/Nagios: the experiments experience. Journal of Physics Conference Series. 396(3). 32100–32100. 5 indexed citations
9.
Harenberg, Job, A. K. Kakkar, D. BERGQVIST, et al.. (2009). Recommendations on biosimilar low‐molecular‐weight heparins. Journal of Thrombosis and Haemostasis. 7(7). 1222–1225. 26 indexed citations
10.
Kakkar, A. K.. (2009). Antithrombotic therapy and survival in cancer patients. Best Practice & Research Clinical Haematology. 22(1). 147–151. 8 indexed citations
11.
12.
Schellong, Sebastian, J. Beyer, A. K. Kakkar, et al.. (2007). Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. Journal of Thrombosis and Haemostasis. 5(7). 1431–1437. 82 indexed citations
13.
Gattuso, J., D Ryan, Clive Wells, et al.. (2007). The role of radiotherapy in treating small early invasive breast cancer. European Journal of Surgical Oncology. 34(4). 369–376. 7 indexed citations
14.
Eriksson, Bengt I., Lars C. Borris, O.E. Dahl, et al.. (2005). Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement. Journal of Thrombosis and Haemostasis. 4(1). 121–128. 246 indexed citations
15.
Monréal, Manuel, A. K. Kakkar, Joseph A. Caprini, et al.. (2004). The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. Journal of Thrombosis and Haemostasis. 2(11). 1892–1898. 135 indexed citations
16.
Levine, Mark N., et al.. (2003). From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. Journal of Thrombosis and Haemostasis. 1(7). 1456–1463. 66 indexed citations
17.
Kakkar, A. K., et al.. (2002). Coagulation proteases and human cancer. Biochemical Society Transactions. 30(2). 201–207. 60 indexed citations
18.
Thodiyil, Paul A., Daniel Walsh, & A. K. Kakkar. (2001). Thromboprophylaxis in the Cancer Patient. Acta Haematologica. 106(1-2). 73–80. 22 indexed citations
19.
Sirivatanauksorn, Yongyut, Vorapan Sirivatanauksorn, Saveri Bhattacharya, et al.. (1999). Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut. 45(5). 761–765. 16 indexed citations
20.
Kakkar, A. K., Vitoon Chinswangwatanakul, Scott J. Tebbutt, Nicholas R. Lemoine, & R C Williamson. (1998). A Characterization of the Coagulant and Fibrinolytic Profile of Human Pancreatic Carcinoma Cells. Pathophysiology of Haemostasis and Thrombosis. 28(1). 1–6. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramón Lecumberri Breakdown of academic impact, for papers by Alejandro Lazo‐Langner Breakdown of academic impact, for papers by J Weitz Breakdown of academic impact, for papers by Theodore E. Spiro Breakdown of academic impact, for papers by Lori‐Ann Linkins Breakdown of academic impact, for papers by A Blanco Breakdown of academic impact, for papers by Edelgard Lindhoff‐Last Breakdown of academic impact, for papers by Pantep Angchaisuksiri Breakdown of academic impact, for papers by O.E. Dahl Breakdown of academic impact, for papers by Rohan Hettiarachchi
Rankless by CCL
2026